First-ever drug to repair DNA and regenerate tissue is here

Humans are poised to receive a Wolverine-like regeneration glow-up, thanks to a new medical breakthrough.

A team of Cedars-Sinai researchers have developed the first-ever drug that can repair damaged DNA and regenerate tissue, according to a new study.

Their discovery, which was two decades in the making, has the potential to transform current treatments for heart attacks, strokes, inflammatory disease, and other major conditions.

What’s going on?

The medical breakthrough centers around a newly isolated RNA molecule, called TY1, that scientists found essentially acts like a cellular janitor.

• TY1 travels to damaged areas in the human body and activates immune cells which rally around damaged DNA and help clear out the molecular “junk” that gets in the way of healing.
• The result is a faster, more efficient repair process that allows the body’s natural recovery and regeneration to occur more efficiently.

In early tests on mice, the molecule helped regenerate heart tissue after injury and reversed inflammation in multiple organ systems, without the need for complex procedures like implanting stem cells or reprogramming DNA.

Big picture: Researchers say their next step is studying TY1 in a human clinical trial, with the goal of developing new treatments for a wide range of conditions, including heart disease and stroke.